| 000 | 01200 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517210241.0 | ||
| 264 | 0 | _c20181127 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1557-8593 | ||
| 024 | 7 |
_a10.1089/dia.2018.0028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLorenz, Carrie | |
| 245 | 0 | 0 |
_aInterference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System. _h[electronic resource] |
| 260 |
_bDiabetes technology & therapeutics _c05 2018 |
||
| 300 |
_a344-352 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcetaminophen |
| 650 | 0 | 4 | _aAscorbic Acid |
| 650 | 0 | 4 |
_aBiosensing Techniques _xmethods |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aBlood Glucose Self-Monitoring _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMannitol |
| 650 | 0 | 4 | _aTetracycline |
| 700 | 1 | _aSandoval, Wendolyn | |
| 700 | 1 | _aMortellaro, Mark | |
| 773 | 0 |
_tDiabetes technology & therapeutics _gvol. 20 _gno. 5 _gp. 344-352 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/dia.2018.0028 _zAvailable from publisher's website |
| 999 |
_c28234011 _d28234011 |
||